CDC Approves Pfizer COVID Booster For Over 65 Adults, Younger With At-risk Jobs

The CDC approved a booster shot of the Pfizer and BioNTech COVID-19 vaccine for Americans aged 65 and older, some adults with underlying medical conditions, and some adults in high-risk working and institutional settings.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.